Is this you? Create Your Porfile
Avatar

Ryo Naito

Astellas Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Ryo Naito is active.

Explore More

Publication

Featured researches published by Ryo Naito.

Archive | 1998

Novel pyrimidine-5-carboxamide derivatives

Hiroyuki Hisamichi; Ryo Naito; Souichirou Kawazoe; Akira Toyoshima; Kazuhito Tanabe; Eiichi Nakai; Atsushi Ichikawa; Akiko Orita; Makoto Takeuchi

Bioorganic & Medicinal Chemistry | 2005

Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure–activity relationships of pyrimidine-5-carboxamide derivatives

Hiroyuki Hisamichi; Ryo Naito; Akira Toyoshima; Noriyuki Kawano; Atsushi Ichikawa; Akiko Orita; Masaya Orita; Noritaka Hamada; Makoto Takeuchi; Mitsuaki Ohta; Shin-ichi Tsukamoto

European Journal of Pharmacology | 2006

The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.

Satoshi Yamamoto; Shingo Sugahara; Ryo Naito; Atsushi Ichikawa; Ken Ikeda; Toshimitsu Yamada; Yasuaki Shimizu

Archive | 2005

2-PHENYLPYRIDINE DERIVATIVE

Junji Miyata; Ryo Naito; Masakatsu Kawakami; Toru Asano

Archive | 2005

2-Phenylthiophene Derivative

Junji Miyata; Masaki Yokota; Ryo Naito; Akio Kamikawa; Masakatsu Kawakami; Kazuyuki Hattori

Archive | 2004

Agent inducing increase in bone mass

Hiroyuki Kanoh; Koichiro Takahashi; Hiromi Nara; Tatsuhiko Yamanoi; Shinji Fukushima; Ryo Naito; Susumu Igarashi

Journal of Medicinal Chemistry | 1998

Synthesis and pharmacological characterization of novel 6-fluorochroman derivatives as potential 5-HT1A receptor antagonists.

Tomoyuki Yasunaga; Takenori Kimura; Ryo Naito; Toru Kontani; Fumikazu Wanibuchi; Hiroshi Yamashita; Tamako Nomura; Shin-ichi Tsukamoto; Tokio Yamaguchi; Toshiyasu Mase

Journal of Medicinal Chemistry | 1997

N-[2-[(substituted chroman-8-yl)oxy]ethyl]-4-(4-methoxyphenyl)butylamines: synthesis and wide range of antagonism at the human 5-HT1A receptor.

Tomoyuki Yasunaga; Ryo Naito; Toru Kontani; Shin-ichi Tsukamoto; Tamako Nomura; Tokio Yamaguchi; Toshiyasu Mase

Bioorganic & Medicinal Chemistry | 2005

Corrigendum to “Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure–activity relationships of pyrimidine-5-carboxamide derivatives” [Bioorg. Med. Chem. 13 (2005) 4936–4951]

Hiroyuki Hisamichi; Ryo Naito; Akira Toyoshima; Noriyuki Kawano; Atsushi Ichikawa; Akiko Orita; Masaya Orita; Noritaka Hamada; Makoto Takeuchi; Mitsuaki Ohta; Shin-ichi Tsukamoto

Bulletin of the Chemical Society of Japan | 2014

Synthesis of Optically Active Thromboxane A2 and Leukotriene D4 Receptor Antagonists

Souichirou Kawazoe; Yoshinori Okamoto; Masaki Yokota; Hirokazu Kubota; Ryo Naito; Makoto Takeuchi; Shigeru Ieda; Minoru Okada; Takeshi Oriyama

Explore More

Collaboration

Dive into the Ryo Naito's collaboration.

Top Co-Authors
Avatar

Atsushi Ichikawa

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Makoto Takeuchi

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Shin-ichi Tsukamoto

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Akiko Orita

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Akira Toyoshima

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Hiroyuki Hisamichi

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Junji Miyata

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Masakatsu Kawakami

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Masaki Yokota

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Masaya Orita

Astellas Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge